MTOR and neoplasm: Since the activation of mTOR has been shown to contribute to tumour progression, it can be speculated that the honokiol-induced inhibition of cell proliferation in HNSCC cells is mediated through the downregulation of EGFR/mTOR signalling pathway [176,192].